Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 248 entries
View as:

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program

Phase: N/A Priority: Normal
NCT ID: NCT01922193 Org: User:
Start: 10/31/13 End: 04/30/15 Due: 04/30/16

Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00209287 Org: User:
Start: 06/30/05 End: 09/30/07 Due: 09/30/08

Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00268892 Org: User:
Start: 01/31/06 End: 12/31/09 Due: 12/31/10

A Study of Pentasa in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01104753 Org: User:
Start: 09/30/09 End: 03/31/11 Due: 03/31/12

Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01387698 Org: User:
Start: 06/30/11 End: 10/31/15 Due: 10/31/16

Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain

Phase: N/A Priority: Normal
NCT ID: NCT03692403 Org: User:
Start: 12/26/18 End: 02/14/22 Due: 02/14/23

Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02468284 Org: User:
Start: 07/31/15 End: 10/10/17 Due: 10/10/18

A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05924321 Org: User:
Start: 05/25/23 End: 09/21/23 Due: 09/21/24

Efficacy, Pharmacokinetics and Safety of Testosterone

Phase: N/A Priority: Normal
NCT ID: NCT01370369 Org: User:
Start: 05/31/11 End: 07/31/11 Due: 07/31/12

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00117286 Org: User:
Start: 03/31/05 End: 11/30/09 Due: 11/30/10

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH

Phase: N/A Priority: Normal
NCT ID: NCT00296465 Org: User:
Start: 02/28/05 End: 11/30/05 Due: 11/30/06

Open-Label, Randomised Parallel-Group Study

Phase: N/A Priority: Normal
NCT ID: NCT00728533 Org: User:
Start: - End: - Due: -

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

Phase: N/A Priority: Normal
NCT ID: NCT02368743 Org: User:
Start: 12/31/15 End: 01/02/18 Due: 01/02/19

Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00819156 Org: User:
Start: 02/29/04 End: 09/30/05 Due: 09/30/06

An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00215683 Org: User:
Start: 02/28/05 End: 11/30/09 Due: 11/30/10

A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00451958 Org: User:
Start: 03/31/07 End: 12/31/11 Due: 12/31/12

CNI-1493 for Treatment of Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00038766 Org: User:
Start: 06/30/02 End: 06/30/03 Due: 06/30/04

User Surveillance in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01363453 Org: User:
Start: 10/31/07 End: 07/31/08 Due: 07/31/09

Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®

Phase: N/A Priority: Normal
NCT ID: NCT03697031 Org: User:
Start: 09/01/18 End: 12/31/20 Due: 12/31/21

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women

Phase: N/A Priority: Normal
NCT ID: NCT01684800 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

AMPLEX Ankle Fusion and Hindfoot

Phase: N/A Priority: Normal
NCT ID: NCT03028415 Org: User:
Start: 07/28/17 End: 07/09/20 Due: 07/09/21

Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina

Phase: N/A Priority: Normal
NCT ID: NCT01861236 Org: User:
Start: 03/31/13 End: 09/03/18 Due: 09/03/19

Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP

Phase: N/A Priority: Normal
NCT ID: NCT01330771 Org: User:
Start: 10/31/06 End: 09/30/08 Due: 09/30/09

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Phase: N/A Priority: Normal
NCT ID: NCT01215513 Org: User:
Start: 09/30/10 End: 04/30/12 Due: 04/30/13

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

Phase: N/A Priority: Normal
NCT ID: NCT02018172 Org: User:
Start: 07/31/14 End: 02/28/15 Due: 02/28/16